Introduction
Shanghai New Shanghua Polymer Material Co., Ltd. (上海新上化高分子材料有限公司) is a Shanghai-based plastics materials manufacturer focused on medical and industrial polymer compounds, with a particular emphasis on medical PVC compounds and films and wire-and-cable materials. The company traces its roots to the Shanghai Chemical Plant, founded in 1924, and has developed over decades into a specialist compound producer with manufacturing operations in Pudong New Area, Shanghai.
In China’s plastics industry, the company is notable for combining long-running technical development, customized compound formulation, and quality-controlled production for regulated end uses such as transfusion products and cable insulation materials. Its reported capabilities include computer-controlled production lines, in-house testing and research facilities, and a manufacturing footprint designed for both medical and industrial polymer processing. The company also holds recognized technical credentials, including designation as a Shanghai Enterprise Technical Center and recognition as a high-tech enterprise in Shanghai.
History and Development
Shanghai New Shanghua’s corporate history is tied to a much older industrial lineage. The company states that it is derived from the Shanghai Chemical Plant established in 1924, positioning it among the long-established participants in China’s polymer materials sector.
Key development milestones include:
- 1999: The company was transformed into Shanghai New Shanghua Polymer Material Co., Ltd.
- 2010: The firm relocated from its earlier Yangpu riverside site to Xinchang Industrial Zone, Pudong, expanding its space for longer-term development; in the same year it introduced a four-roller calendar machine and reported successful trial production.
- 2011: The company was again recognized as a Shanghai Enterprise Technical Center, reinforcing its role as a technology-oriented compound producer.
Later public records also identify the company as a high-tech enterprise in Shanghai in 2020, and municipal innovation programs have listed company patents in connection with industrialization support for proprietary technologies.
Business Operations and Segments
The company describes its core business as the research, development, production, and sales of medical and industrial polymer materials. Its operations are concentrated in two principal segments:
- Medical polymer materials, especially PVC compounds and PVC films used in transfusion and related disposable medical products.
- Wire-and-cable materials, including XLPE compounds and other cable insulation materials used in electrical applications.
Public business directories and product listings also associate the company with a broader processing scope that includes extrusion services, thermoplastics processing, and plastic articles for packaging and electrical uses, although the company’s own descriptions emphasize medical and cable applications as its main focus.
The company reports that it operates 15 fully computer-controlled production lines and a workforce including product engineers, researchers, quality managers, and technicians. It also states an annual capacity of more than 50,000 tonnes, while another public employment posting references annual output of 35,000 tonnes for selected product lines; the difference likely reflects variation in reporting date or product scope rather than a direct contradiction.
Products and Technologies
The company’s product portfolio centers on polymer compounds rather than finished medical devices or cable systems. Publicly described product classes include:
| Product category | Typical uses | Technical notes |
|---|---|---|
| Medical PVC compound | Transfusion tubing, blood bags, suction catheters, nasal oxygen tubes, lung tubes | Formulated for medical processing and regulated end use; used in calendering and film applications. |
| Calendered PVC film | Traditional blood bags and related medical films | The company states that production includes plasticizing, calendering, embossing, and cooling. |
| XLPE compound for cable | Cable insulation and wire-and-cable applications | Linked to silane-crosslinkable and cable-grade polyethylene formulations. |
| Cable plastics and related compounds | Electrical and industrial cable applications | The company emphasizes performance-oriented polymer materials for electrical systems. |
The firm’s technical profile is strengthened by its in-house laboratory and testing capabilities, which it says support product analysis, development, quality assurance, and process improvement. The company has also published product-specific pages for calendered PVC film and silane XLPE compound, indicating a focused capability in both medical film conversion and crosslinkable polyethylene formulation.
Applications and End Markets
Shanghai New Shanghua’s materials are used across a wide range of downstream industries. The company states that its products are applied in:
- Medical devices and disposable medical products
- Wire and cable manufacturing
- Electronics
- Machinery and industrial equipment
- Defense-related industrial uses
- Construction
- Automotive manufacturing
- Transportation infrastructure
- Power equipment and stations
This end-market mix reflects a common feature of the plastics compounds sector: suppliers often sell engineered formulations into industries that require consistent processing behavior, stable mechanical properties, and, in medical applications, stringent quality control.
Global Presence and Market Position
The company is headquartered in Xinchang Industrial Zone, Pudong, Shanghai, and has long served customers across mainland China. It reports sales to 26 provinces, municipalities, and autonomous regions and says it maintains more than 300 long-term customers. Public listings also indicate commercial visibility in international B2B directories and trade platforms, though the company’s strongest documented market presence remains in China.
Its market position is best understood as that of a specialized domestic compound supplier with particular strength in medical PVC and cable compounds, rather than a broad-based multinational polymer producer. The company’s “Shuanghua” trademark is identified as a Shanghai famous trademark, while “SHNSH” is used for export products.
Sustainability and Environmental Initiatives
Publicly available source material provides limited detail on the company’s sustainability program. The most visible environmental implication of its business model is the supply of durable engineering compounds and medical materials that are designed for controlled industrial use, but the available sources do not provide a formal emissions, recycling, or lifecycle disclosure.
From an industry perspective, the company operates in segments that are under increasing pressure to address medical plastics waste, PVC recyclability, and energy efficiency in compounding and extrusion. However, no source in the available record provides company-specific quantitative sustainability targets or audited environmental metrics, so such claims should not be inferred.
Financial Performance and Economic Impact
No audited financial statements or detailed revenue disclosures were included in the provided sources. Based on available materials, the company appears to be a mid-sized specialized manufacturer with a significant production base and stable domestic customer network rather than a publicly listed enterprise with extensive market disclosure.
Its economic impact is primarily industrial and regional:
- support for Shanghai’s advanced materials base
- supply of critical compound materials to medical and cable manufacturers
- contribution to local employment and technical capability in Pudong
The company’s reported annual production capacity of more than 50,000 tonnes indicates a meaningful role in downstream plastics supply chains, especially where continuity of material quality is essential.
Leadership and Corporate Governance
Public company directory information identifies the firm as a limited liability company under Chinese law, with continuing operations and an established registered address in Pudong. The available sources also identify Xu Yongwei as a legal representative in one business directory record.
The company describes itself as having a “well-established governance system” and a management structure supported by technical and quality professionals. Source material does not provide a full board composition or detailed governance framework, so deeper corporate governance analysis is not possible from the current record.
Innovations and Future Outlook
Shanghai New Shanghua’s innovation profile is centered on compound formulation, medical-material processing, and cable-material performance optimization. Its patent-related public listings and repeated recognition as a high-tech enterprise suggest ongoing investment in proprietary process and material technologies.
The company’s future prospects are likely tied to several industry trends:
- continued demand for medical polymer materials in regulated healthcare supply chains
- growth in wire-and-cable materials driven by power infrastructure, electrification, and industrial upgrading
- ongoing pressure to improve process efficiency, material consistency, and specialty-performance formulations in competitive compound markets
Its ability to sustain its position will depend on maintaining quality certification, adapting formulations to evolving application standards, and continuing to convert technical know-how into differentiated products.
Summary
Shanghai New Shanghua Polymer Material Co., Ltd. is a long-established Shanghai polymer compound producer with a heritage linked to the Shanghai Chemical Plant of 1924 and a contemporary focus on medical PVC and wire-and-cable polymers. Its combination of technical-center recognition, specialized product lines, and manufacturing scale has made it a notable participant in China’s engineered plastics sector.
References
- •
CPS+ eMarketplace. (n.d.). SHANGHAI NEW SHANGHUA POLYMER MATERIAL CO., LTD.SHANGHAI NEW SHANGHUA POLYMER MATERIAL CO., LTD.. CPS+ eMarketplace. https://www.chinaplasonline.com/eMarketplace/ExhibitorInfo?CompId=1016607Link